Ratings by Citi (Yigal Nochomovitz)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
9/22/2021 Innate Pharma S.A. IPHA Maintain Buy
(N/A)
 
 
  Details
9/8/2021 Applied Therapeutics APLT Maintain Buy
(N/A)
 
 
  Details
8/30/2021 Lexicon Pharmaceuticals LXRX Maintain Buy
(N/A)
 
 
  Details
8/25/2021 Arcturus Therapeutics ARCT Maintain Buy
(N/A)
 
 
  Details
8/17/2021 Caribou Biosciences Inc. CRBU New Coverage Neutral
(N/A)
26.48
(24.24)
-8.46% Details
8/13/2021 Mirati Therapeutics MRTX Maintain Buy
(N/A)
 
 
  Details
8/13/2021 ProQR Therapeutics N.V. PRQR Maintain Buy
(N/A)
 
 
  Details
8/13/2021 Dicerna Pharmaceuticals DRNA Maintain Buy
(N/A)
 
 
  Details
8/11/2021 Zai Lab ZLAB Maintain Buy
(N/A)
 
 
  Details
8/9/2021 Arcus Biosciences RCUS Maintain Buy
(N/A)
 
 
  Details
8/9/2021 Eiger BioPharma EIGR Maintain Buy
(N/A)
 
 
  Details
8/9/2021 Dicerna Pharmaceuticals DRNA Downgrade Neutral
(Buy)
37.92
(21.30)
-43.83% Details
7/23/2021 Arvinas Inc. ARVN Maintain Buy
(N/A)
 
 
  Details
6/28/2021 Unity Biotechnology Inc UBX Upgrade Buy
(Sell)
4.34
(2.94)
-32.26% Details
6/14/2021 CRISPR Therapeutics CRSP Upgrade Neutral
(Sell)
123.71
(116.43)
-5.88% Details
6/8/2021 Harpoon Therapeutics HARP Downgrade Neutral
(Buy)
15.27
(7.96)
-47.87% Details
6/7/2021 Merus N.V. MRUS Upgrade Buy
(Neutral)
20.68
(22.21)
7.4% Details
6/4/2021 Mirati Therapeutics MRTX Upgrade Buy
(Neutral)
154.86
(166.36)
7.43% Details
5/26/2021 Puma Biotechnology PBYI Maintain Neutral
(N/A)
 
 
  Details
5/25/2021 Syndax Pharmaceuticals SNDX New Coverage Buy
(N/A)
17.69
(18.80)
6.27% Details
5/21/2021 CRISPR Therapeutics CRSP Maintain Sell
(N/A)
 
 
  Details
5/21/2021 Arcus Biosciences RCUS Maintain Buy
(N/A)
 
 
  Details
5/20/2021 Reata Pharmaceuticals RETA Maintain Buy
(N/A)
 
 
  Details
5/12/2021 Imara Inc. IMRA New Coverage Buy
(N/A)
7.46
(4.20)
-43.7% Details
5/11/2021 Eiger BioPharma EIGR Maintain Buy
(N/A)
 
 
  Details
5/6/2021 Ultragenyx Pharma RARE Upgrade Buy
(Neutral)
101.85
(95.11)
-6.62% Details
3/25/2021 ProQR Therapeutics N.V. PRQR Maintain Buy
(N/A)
 
 
  Details
3/4/2021 Ovid Therapeutics Inc OVID Maintain Neutral
(N/A)
 
 
  Details
3/2/2021 Atara Biotherapeutics ATRA Upgrade Buy
(Neutral)
17.10
(17.00)
-0.58% Details
3/1/2021 Acceleron Pharma XLRN Maintain Buy
(N/A)
 
 
  Details
2/16/2021 Unity Biotechnology Inc UBX Downgrade Sell
(Neutral)
8.28
(2.94)
-64.49% Details
2/11/2021 Fate Therapeutics FATE Downgrade Neutral
(Buy)
103.31
(64.85)
-37.23% Details
1/28/2021 Zymeworks ZYME Upgrade Buy
(Neutral)
44.06
(28.52)
-35.27% Details
1/25/2021 Zymeworks ZYME Downgrade Neutral
(Buy)
52.16
(28.52)
-45.32% Details
1/15/2021 Zai Lab ZLAB Maintain Buy
(N/A)
 
 
  Details
1/14/2021 Lexicon Pharmaceuticals LXRX Maintain Buy
(N/A)
 
 
  Details
1/8/2021 Aldeyra Therapeutics ALDX Maintain Buy
(N/A)
 
 
  Details
12/15/2020 Arvinas Inc. ARVN Maintain Buy
(N/A)
 
 
  Details
12/14/2020 Arcturus Therapeutics ARCT Maintain Buy
(N/A)
 
 
  Details
12/9/2020 Atara Biotherapeutics ATRA Downgrade Neutral
(Buy)
26.23
(17.10)
-34.81% Details
12/8/2020 Lexicon Pharmaceuticals LXRX Upgrade Buy
(Neutral)
1.58
(4.94)
212.66% Details
12/7/2020 Fate Therapeutics FATE Maintain Buy
(N/A)
 
 
  Details
12/2/2020 Ovid Therapeutics Inc OVID Downgrade Neutral
(Buy)
6.84
(3.45)
-49.56% Details
11/25/2020 Reata Pharmaceuticals RETA Maintain Buy
(N/A)
 
 
  Details
11/23/2020 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
11/11/2020 Dicerna Pharmaceuticals DRNA Maintain Buy
(N/A)
 
 
  Details
11/11/2020 Cellectis CLLS Maintain Buy
(N/A)
 
 
  Details
11/10/2020 Reata Pharmaceuticals RETA Maintain Buy
(N/A)
 
 
  Details
11/9/2020 Aerie Pharma AERI Maintain Buy
(N/A)
 
 
  Details
11/9/2020 Fate Therapeutics FATE Maintain Buy
(N/A)
 
 
  Details
10/28/2020 Galera Therapeutics GRTX Maintain Buy
(N/A)
 
 
  Details
10/6/2020 Arcturus Therapeutics ARCT New Coverage Buy
(N/A)
49.97
(50.71)
1.48% Details
9/18/2020 Mirati Therapeutics MRTX Downgrade Neutral
(Buy)
161.97
(166.36)
2.71% Details
8/19/2020 Cellectis CLLS Upgrade Buy
(Buy)
17.22
(13.41)
-22.13% Details
8/18/2020 Unity Biotechnology Inc UBX Downgrade Neutral
(Buy)
12.43
(2.94)
-76.35% Details
8/17/2020 Imara Inc. IMRA Upgrade Buy
(Neutral)
20.61
(4.20)
-79.62% Details
8/11/2020 Reata Pharmaceuticals RETA Maintain Buy
(N/A)
 
 
  Details
8/10/2020 Harpoon Therapeutics HARP Maintain Buy
(N/A)
 
 
  Details
8/3/2020 MacroGenics MGNX Downgrade Neutral
(Buy)
26.75
(19.74)
-26.21% Details
7/13/2020 Rigel Pharmaceuticals RIGL Maintain Buy
(N/A)
 
 
  Details
6/30/2020 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
6/30/2020 Harpoon Therapeutics HARP Maintain Buy
(N/A)
 
 
  Details
6/30/2020 Imara Inc. IMRA Downgrade Neutral
(Buy)
34.23
(4.20)
-87.73% Details
6/26/2020 Translate Bio TBIO Maintain Buy
(N/A)
 
 
  Details
6/5/2020 Unity Biotechnology Inc UBX Maintain Buy
(N/A)
 
 
  Details
6/5/2020 Mirati Therapeutics MRTX Maintain Buy
(N/A)
 
 
  Details
6/5/2020 Galera Therapeutics GRTX Maintain Buy
(N/A)
 
 
  Details
6/5/2020 Eiger BioPharma EIGR Maintain Buy
(N/A)
 
 
  Details
6/2/2020 Zymeworks ZYME Maintain Buy
(N/A)
 
 
  Details
6/2/2020 Acceleron Pharma XLRN Maintain Buy
(N/A)
 
 
  Details
6/1/2020 Arvinas Inc. ARVN Upgrade Buy
(Neutral)
44.85
(88.61)
97.57% Details
5/8/2020 Ultragenyx Pharma RARE Maintain Neutral
(N/A)
 
 
  Details
5/8/2020 Aerie Pharma AERI Maintain Buy
(N/A)
 
 
  Details
5/5/2020 Portola Pharmaceuticals PTLA Downgrade Neutral
(Buy)
7.76
(18.03)
132.35% Details
4/28/2020 Lexicon Pharmaceuticals LXRX Maintain Neutral
(N/A)
 
 
  Details
4/28/2020 Lexicon Pharmaceuticals LXRX Maintain Neutral
(N/A)
 
 
  Details
4/23/2020 Atara Biotherapeutics ATRA Upgrade Buy
(Neutral)
8.00
(17.00)
112.5% Details
4/6/2020 Imara Inc. IMRA New Coverage Buy
(N/A)
15.75
(4.20)
-73.33% Details
3/31/2020 Reata Pharmaceuticals RETA Maintain Buy
(N/A)
 
 
  Details
3/16/2020 Lexicon Pharmaceuticals LXRX Maintain Neutral
(N/A)
 
 
  Details
3/12/2020 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
3/4/2020 CRISPR Therapeutics CRSP Maintain Sell
(N/A)
 
 
  Details
3/2/2020 Acceleron Pharma XLRN Maintain Buy
(N/A)
 
 
  Details
2/26/2020 MacroGenics MGNX Maintain Buy
(N/A)
 
 
  Details
2/24/2020 Aerie Pharma AERI Maintain Buy
(N/A)
 
 
  Details
2/12/2020 Ardelyx, Inc ARDX New Coverage Buy
(N/A)
7.33
(1.31)
-82.13% Details
1/28/2020 Acceleron Pharma XLRN Maintain Buy
(N/A)
 
 
  Details
1/24/2020 Zai Lab ZLAB Maintain Buy
(N/A)
 
 
  Details
1/21/2020 Acceleron Pharma XLRN Maintain Buy
(N/A)
 
 
  Details
1/13/2020 Ultragenyx Pharma RARE Maintain Neutral
(N/A)
 
 
  Details
1/13/2020 Portola Pharmaceuticals PTLA Maintain Buy
(N/A)
 
 
  Details
1/9/2020 Applied Therapeutics APLT Maintain Buy
(N/A)
 
 
  Details
1/8/2020 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
1/7/2020 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
12/29/2019 Zai Lab ZLAB Maintain Buy
(N/A)
 
 
  Details
12/19/2019 Aerie Pharma AERI New Coverage Buy
(N/A)
21.92
(11.79)
-46.21% Details
12/18/2019 Dicerna Pharmaceuticals DRNA Maintain Buy
(N/A)
 
 
  Details
12/2/2019 Galera Therapeutics GRTX New Coverage Buy
(N/A)
12.53
(7.92)
-36.79% Details
11/19/2019 ProQR Therapeutics N.V. PRQR Maintain Buy
(N/A)
 
 
  Details
11/18/2019 Ovid Therapeutics Inc OVID Maintain Buy
(N/A)
 
 
  Details
11/18/2019 CRISPR Therapeutics CRSP Maintain Sell
(N/A)
 
 
  Details
11/8/2019 Lexicon Pharmaceuticals LXRX Downgrade Neutral
(Buy)
3.88
(4.94)
27.32% Details
11/7/2019 Ultragenyx Pharma RARE Maintain Neutral
(N/A)
 
 
  Details
11/7/2019 MacroGenics MGNX Maintain Buy
(N/A)
 
 
  Details
10/15/2019 Reata Pharmaceuticals RETA Maintain Buy
(N/A)
 
 
  Details
10/11/2019 ProQR Therapeutics N.V. PRQR Maintain Buy
(N/A)
 
 
  Details
10/9/2019 Portola Pharmaceuticals PTLA Maintain Buy
(N/A)
 
 
  Details
9/24/2019 Ovid Therapeutics Inc OVID Maintain Buy
(N/A)
 
 
  Details
9/17/2019 Acceleron Pharma XLRN Maintain Buy
(N/A)
 
 
  Details
9/10/2019 Translate Bio TBIO Maintain Buy
(N/A)
 
 
  Details
9/4/2019 Zai Lab ZLAB Maintain Buy
(N/A)
 
 
  Details
8/27/2019 Zymeworks ZYME Maintain Buy
(N/A)
 
 
  Details
8/21/2019 NuCana NCNA Maintain Buy
()
 
 
  Details
8/21/2019 Synlogic Inc. SYBX Downgrade Sell
(Buy)
4.83
(3.17)
-34.37% Details
8/12/2019 ProQR Therapeutics N.V. PRQR Maintain Buy
(N/A)
 
 
  Details
8/12/2019 Atara Biotherapeutics ATRA Maintain Neutral
(N/A)
 
 
  Details
8/8/2019 Portola Pharmaceuticals PTLA Maintain Buy
(N/A)
 
 
  Details
8/8/2019 Portola Pharmaceuticals PTLA Maintain Buy
(N/A)
 
 
  Details
8/7/2019 Acceleron Pharma XLRN Maintain Buy
(N/A)
 
 
  Details
8/7/2019 Mirati Therapeutics MRTX Maintain Buy
(N/A)
 
 
  Details
8/5/2019 Ultragenyx Pharma RARE Maintain Neutral
(N/A)
 
 
  Details
7/30/2019 Lexicon Pharmaceuticals LXRX Maintain Buy
(N/A)
 
 
  Details
7/3/2019 Dicerna Pharmaceuticals DRNA Maintain Buy
(Buy)
 
 
  Details
6/26/2019 Aldeyra Therapeutics ALDX Maintain Buy
(N/A)
 
 
  Details
6/26/2019 Eiger BioPharma EIGR New Coverage Buy
(N/A)
10.61
(7.00)
-34.02% Details
6/13/2019 Synlogic Inc. SYBX Maintain Buy
(N/A)
 
 
  Details
6/7/2019 Puma Biotechnology PBYI Maintain Neutral
(N/A)
 
 
  Details
6/5/2019 Arvinas Inc. ARVN Downgrade Neutral
(Buy)
20.05
(44.85)
123.69% Details
6/4/2019 Mirati Therapeutics MRTX Upgrade Buy
(Neutral)
89.20
(166.36)
86.5% Details
6/4/2019 Atara Biotherapeutics ATRA Upgrade Neutral
(Sell)
22.21
(17.00)
-23.46% Details
5/24/2019 Acceleron Pharma XLRN Maintain Buy
(N/A)
 
 
  Details
5/24/2019 Cellectis CLLS New Coverage Neutral
(N/A)
18.34
(13.41)
-26.88% Details
5/24/2019 Acceleron Pharma XLRN New Coverage Buy
(N/A)
43.25
(167.65)
287.63% Details
5/24/2019 Arcus Biosciences RCUS New Coverage Buy
(N/A)
9.52
(35.97)
277.84% Details
5/15/2019 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
5/13/2019 Mirati Therapeutics MRTX Maintain Neutral
(N/A)
 
 
  Details
5/10/2019 Puma Biotechnology PBYI Downgrade Neutral
(Buy)
30.02
(6.82)
-77.28% Details
5/2/2019 Lexicon Pharmaceuticals LXRX Maintain Buy
(N/A)
 
 
  Details
4/18/2019 Ultragenyx Pharma RARE Maintain Neutral
(N/A)
 
 
  Details
3/21/2019 Merus N.V. MRUS Maintain Neutral
(N/A)
 
 
  Details
3/20/2019 Akebia Therapeutics AKBA New Coverage Neutral
(N/A)
8.17
(2.86)
-64.99% Details
3/15/2019 Merus N.V. MRUS Maintain Neutral
(N/A)
 
 
  Details
3/15/2019 Ovid Therapeutics Inc OVID Maintain Buy
(N/A)
 
 
  Details
3/15/2019 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
3/6/2019 Chimerix CMRX Maintain Neutral
(N/A)
 
 
  Details
3/4/2019 Portola Pharmaceuticals PTLA Maintain Buy
(N/A)
 
 
  Details
3/4/2019 Puma Biotechnology PBYI Maintain Buy
(N/A)
 
 
  Details
3/4/2019 Portola Pharmaceuticals PTLA Maintain Buy
(Buy)
 
 
  Details
3/4/2019 Mirati Therapeutics MRTX Downgrade Neutral
(Buy)
72.80
(89.20)
22.53% Details
3/1/2019 Puma Biotechnology PBYI Maintain Buy
(N/A)
 
 
  Details
2/21/2019 Ultragenyx Pharma RARE Maintain Neutral
(N/A)
 
 
  Details
2/20/2019 Ultragenyx Pharma RARE Maintain Neutral
(N/A)
 
 
  Details
2/20/2019 ProQR Therapeutics N.V. PRQR Maintain Buy
(N/A)
 
 
  Details
2/7/2019 MacroGenics MGNX Upgrade Buy
(Sell)
11.11
(19.74)
77.68% Details
2/4/2019 MacroGenics MGNX Downgrade Sell
(Neutral)
11.73
(11.11)
-5.29% Details
1/24/2019 Rigel Pharmaceuticals RIGL Maintain Buy
(N/A)
 
 
  Details
1/22/2019 CRISPR Therapeutics CRSP Downgrade Sell
(Neutral)
37.13
(116.43)
213.57% Details
1/18/2019 Lexicon Pharmaceuticals LXRX Maintain Buy
(N/A)
 
 
  Details
1/2/2019 Merus N.V. MRUS Maintain Neutral
(N/A)
 
 
  Details
12/6/2018 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
12/4/2018 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
12/4/2018 Aldeyra Therapeutics ALDX New Coverage Buy
(N/A)
8.97
(8.50)
-5.24% Details
11/27/2018 Zymeworks ZYME Maintain Buy
(N/A)
 
 
  Details
11/27/2018 LOXO Maintain Buy
(N/A)
 
 
  Details
11/16/2018 Rigel Pharmaceuticals RIGL Maintain Buy
(N/A)
 
 
  Details
11/15/2018 ProQR Therapeutics N.V. PRQR New Coverage Buy
(N/A)
18.67
(7.79)
-58.28% Details
11/9/2018 Chimerix CMRX Maintain Neutral
(N/A)
 
 
  Details
11/8/2018 Ultragenyx Pharma RARE Upgrade Neutral
(Sell)
54.34
(95.11)
75.03% Details
11/7/2018 Portola Pharmaceuticals PTLA Maintain Buy
(N/A)
 
 
  Details
11/5/2018 Puma Biotechnology PBYI Maintain Buy
(N/A)
 
 
  Details
11/2/2018 Lexicon Pharmaceuticals LXRX Maintain Buy
(N/A)
 
 
  Details
10/29/2018 Ultragenyx Pharma RARE Maintain Sell
(N/A)
 
 
  Details
10/22/2018 Arvinas Inc. ARVN New Coverage Buy
(N/A)
15.56
(20.05)
28.86% Details
9/28/2018 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
9/18/2018 Puma Biotechnology PBYI Maintain Buy
(N/A)
 
 
  Details
9/14/2018 Zai Lab ZLAB Maintain Buy
(N/A)
 
 
  Details
9/5/2018 Synlogic Inc. SYBX Maintain Buy
(N/A)
 
 
  Details
8/27/2018 Rigel Pharmaceuticals RIGL New Coverage Buy
(N/A)
2.80
(3.74)
33.57% Details
8/24/2018 CRISPR Therapeutics CRSP Maintain Neutral
(N/A)
 
 
  Details
8/24/2018 Synlogic Inc. SYBX Upgrade Buy
(Neutral)
7.91
(4.83)
-38.94% Details